Orpegen Pharma GmbH
Records under this name other than patents Orpegen Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Orpegen Pharma GmbH
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,835,551 | Basophil degranulation test Formerly held Term ended Term ended Mar 1, 2019 · USPTO record | Term ended | Term ended Mar 1, 2019 | USPTO record |
| US 5,902,733 | Test system for determining the activity of natural killer cells Formerly held Term ended Term ended no later than May 11, 2019 · Low confidence | Term ended | Term ended no later than May 11, 2019 | Low confidence |